Showing results (11-20 of 43) with videos related to
Sort By:
Pageof 5
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 29, 2009
Hepatocellular carcinoma complicating cystic fibrosis related liver diseaseD H O'Donnell, R Ryan, B Hayes, et al.Irish Medical Journal|July 19, 2012
Successful use of combined high cut-off haemodialysis and bortezomib for acute kidney injury associated with myeloma cast nephropathyF Ward, O Dunne, T B Crotty, et al.Seminars in Oncology|October 1, 1995
Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancerA D Seidman, C A Hudis, D Fennelly, et al.Oncology (Williston Park, N.Y.)|March 1, 1997
Paclitaxel for breast cancer: the Memorial Sloan-Kettering Cancer Center experienceA D Seidman, C A Hudis, G Raptis, et al.The Canadian Journal of Oncology|December 1, 1995
High-dose chemotherapy of breast cancerJ Crown, G Raptis, N Hamilton, et al.Seminars in Oncology|November 5, 1997
Salvage weekly paclitaxel in recurrent ovarian cancerN R Abu-Rustum, C Aghajanian, R R Barakat, et al.European Journal of Gynaecological Oncology|January 1, 1997
Salvage intraperitoneal therapy of advanced epithelial ovarian cancer: impact of retroperitoneal nodal diseaseR R Barakat, D Fennelly, F Pizzuto, et al.Gynecologic Oncology|April 1, 1996
The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancerH Gogas, F Shapiro, C Aghajanian, et al.Seminars in Oncology|August 15, 1998
New chemotherapy combinations with docetaxel in the treatment of patients with non-small cell lung cancerP Donnellan, J Armstrong, S Rowan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancerD Fennelly, C Aghajanian, F Shapiro, et al.Pageof 5